XTANT MEDICAL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 5.08 billion shares for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2024-04-01
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-12-31 was 5.07B shares.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2021-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2021-09-30 was 7.10B shares.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2021-06-30 was 0.00 shares.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 5.08B shares, a 28.61% decline from fiscal 2021.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2021 was 7.11B shares, a 196.30% increase from fiscal 2020.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2020 was 2.40B shares, a 199900.00% increase from fiscal 2019.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2019 was 1.20M shares, a 0.00% change from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | 5.07B shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 5.08B shares 10-K · filed 2024-04-01 | |||
| 2022-09-30 | 3.52M shares 10-Q · filed 2022-11-03 | ||||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 7.10B shares derived: sum of 2 quarters · filed 2023-03-07 | 7.10B shares derived: sum of 3 quarters · filed 2023-03-07 | 7.11B shares 10-K · filed 2023-03-07 | |
| 2021-09-30 | 7.10B shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 7.10B shares derived: sum of 2 quarters · filed 2021-11-12 | 7.11B shares 10-Q · filed 2021-11-12 | 9.51B shares derived: sum of 4 quarters · filed 2022-03-08 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 7.11M shares 10-Q · filed 2021-08-05 | 2.40B shares derived: sum of 3 quarters · filed 2022-03-08 | 2.40B shares derived: sum of 4 quarters · filed 2022-03-08 | |
| 2021-03-31 | 7.11M shares 10-Q · filed 2021-05-11 | 2.40B shares derived: sum of 2 quarters · filed 2022-03-08 | 2.40B shares derived: sum of 3 quarters · filed 2022-03-08 | ||
| 2020-12-31 | 2.40B shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 2.40B shares derived: sum of 2 quarters · filed 2022-03-08 | 2.40B shares 10-K · filed 2022-03-08 | 2.40M shares 10-K · filed 2021-02-24 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | 2.40M shares 10-Q · filed 2020-10-29 | |||
| 2020-06-30 | 2.40M shares 10-Q · filed 2020-08-03 | ||||
| 2019-12-31 | 1.20M shares 10-K · filed 2021-02-24 | ||||
| 2018-12-31 | 1.20M shares 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |